YUPELRI approved by China's NMPA as the first once-daily nebulized LAMA for maintenance treatment of COPD <li /> Approval triggers ...

A quarter of people seeking care for symptoms of chronic respiratory diseases in Kenya may incur "catastrophic" health costs, ...

Compared with tezepelumab, solrikitug demonstrated unique epitope binding and superior potency across several assays.

Men, particularly after the age of 35, face a higher risk of developing chronic illnesses than women. While genetics and ageing play a role, many of these conditions are largely influenced ...

Mumbai: Global pharma major Lupin Limited has received a green light from the United States Food and Drug Administration (U.S ...

The deep cuts to Medicaid outlined in President Trump’s budget reconciliation bill would hurt Americans suffering from conditions like chronic obstructive pulmonary disease (COPD), Rep. Maxine ...

Researchers discover an unusual accumulation of particles in people with the disease; the causes are still unclear.

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

Nektar’s shares have surged more than twofold after a Phase IIb study of its atopic dermatitis (AD) therapy rezpegaldesleukin ...

Yoga can be a valuable complement to pulmonary therapy for chronic respiratory diseases, such as COPD and asthma. By ...

According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...

Fatigue is one of the most common symptoms of COPD, so it's important to understand what causes it, columnist Caroline Gainer says.